The extraordinary ligand binding properties of human serum albumin.
about
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albuminStructure, properties, and engineering of the major zinc binding site on human albuminHuman serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurementsDrug Carrier for Photodynamic Cancer TherapyHeme-based catalytic properties of human serum albuminThermodynamics and solvent linkage of macromolecule-ligand interactionsUnraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based TherapeuticsSynthetic cationic antimicrobial peptides bind with their hydrophobic parts to drug site II of human serum albuminEngineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic DeliverySimple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapyHigh-throughput 1,536-well fluorescence polarization assays for α(1)-acid glycoprotein and human serum albumin bindingHuman serum albumin and p53-activating peptide fusion protein is able to promote apoptosis and deliver fatty acid-modified moleculesDifferential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albuminAlbumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin.Binding of Sulpiride to Seric Albumins.Understanding the effects of two bound glucose in Sudlow site I on structure and function of human serum albumin: theoretical studies.Differential modulation in binding of ketoprofen to bovine serum albumin in the presence and absence of surfactants: spectroscopic and calorimetric insights.Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.Fibrinogen species as resolved by HPLC-SAXS data processing within the UltraScan Solution Modeler (US-SOMO) enhanced SAS module.Lanthanide(III) complexes of rhodamine-DO3A conjugates as agents for dual-modal imagingGenome-Wide Identification and Comparative Analysis of Albumin Family in Vertebrates.The interaction of serum albumin with ginsenoside Rh2 resulted in the downregulation of ginsenoside Rh2 cytotoxicity.Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin.Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis.Chromatographic analysis of acetohexamide binding to glycated human serum albuminBinding of tolbutamide to glycated human serum albuminThermodynamic stability and relaxation studies of small, triaza-macrocyclic Mn(II) chelates.Albuminoid genes: evolving at the interface of dispensability and selectionReciprocal allosteric modulation of carbon monoxide and warfarin binding to ferrous human serum heme-albuminMR lymphangiography with intradermal gadofosveset and human serum albumin in mice and primates.Design and characterization of protein-quercetin bioactive nanoparticles.Analysis of high affinity self-association by fluorescence optical sedimentation velocity analytical ultracentrifugation of labeled proteins: opportunities and limitations.Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.Reversible exposure of hydrophobic residues on albumin as a novel strategy for formulation of nanodelivery vehicles for taxanes.A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid.Safety Evaluation of Hemoglobin-Albumin Cluster "HemoAct" as a Red Blood Cell Substitute.Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni.Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats
P2860
Q24652314-F532082A-9B32-4517-BB15-3F4EAD56CF68Q24658366-CEC7B299-65E1-4EEB-BD31-2B8D2A8E35D6Q26739820-441F0936-A7ED-4A3C-8913-F9C4A4F157D7Q26782780-C69845DB-329E-4219-8695-AB75417816E9Q26828438-F9C807B3-1E9A-4FBC-8071-854E5F3E74DEQ27024230-1A012F9D-4741-4D43-9C52-00840CED1692Q27027238-1A9FCF5B-A4E1-4C1E-A5BE-442739A50BCEQ27681441-BB6F77E2-3C70-4460-A29D-7D585F743CEAQ28087367-E1A06986-185F-4AF2-B964-0EA9739718BBQ28397980-BF78A28D-72E5-4999-AEBA-9459BA3DD6D7Q28483928-0AFA2D9A-C488-4377-9779-D68C3E463E26Q28535347-01E075E8-C2C3-44A8-9E35-6AAC454F2FE9Q28539455-09605A6D-7FC8-4156-AD1E-18934F7ACB40Q30252682-14F6395C-DF7C-43F4-BE79-232905F622EDQ30383282-7CF63D9A-0264-454C-B907-77CF17ECDAA3Q30385277-EA6B03CD-885C-4F7D-B8F4-28A3DE57864CQ30428555-D712E0FE-5494-43BE-A6CB-45C5FCEAD6E7Q30575408-87294EA2-DBF2-4E94-ABD2-8186066BF070Q30702699-CE19877A-D28B-487C-95A3-D133C0FA5C12Q33623967-8D538352-8FA7-456C-A66C-21C448708762Q33824988-8AF71F4A-B3FE-4FAF-8B39-61C0E05FD236Q33850000-43EF4354-4F2F-4FEA-955D-7D43DD9ED92CQ33851532-E62064E8-765C-4AEA-83CE-29A52DD8AD64Q33876316-E111781F-386D-4EA9-BA6A-E5A7DFAF9184Q34009043-AC24F037-91F5-4557-B5CB-FBD0E9775B42Q34058356-5FA0BA4B-8ED3-4C13-B073-F7FEDE07C8D5Q34189372-AC047A32-F872-4C8A-846F-E9E186A4704EQ34233297-D1FFEBCD-6658-496D-89DA-105627109144Q34561711-C73452BF-B546-4DD7-9790-44D7AFF1760DQ34631727-236AEF5B-EBD5-4B7F-8877-84B8B3EAA1DBQ34650567-922D2F4A-84C4-4F2E-9EEE-0F434B0BD587Q34916107-7C8D6104-35EE-4974-AE60-7AE9AAF8D74DQ35049363-7537B8E3-E2A0-45CE-9870-93FAAEE0AEBEQ35073088-57BF43AF-7E82-48F9-BF82-860600F988B7Q35132298-82D853CF-855E-4DAB-A43D-50E9A7BCD129Q35143239-97070390-8A83-4655-ABBF-52DA88C9C3BEQ35156254-E71BF509-E8F1-43CC-8A37-51DBBA5AC1ECQ35898256-FA06BBC8-27C3-4490-A366-78A2A006BDB8Q35944679-BF3B864A-43AD-4EDD-AE5E-4E0F7DC37F0CQ35945879-B93A0A86-C4E7-451B-BAB1-8A299E9040D5
P2860
The extraordinary ligand binding properties of human serum albumin.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The extraordinary ligand binding properties of human serum albumin.
@ast
The extraordinary ligand binding properties of human serum albumin.
@en
type
label
The extraordinary ligand binding properties of human serum albumin.
@ast
The extraordinary ligand binding properties of human serum albumin.
@en
prefLabel
The extraordinary ligand binding properties of human serum albumin.
@ast
The extraordinary ligand binding properties of human serum albumin.
@en
P2093
P50
P1433
P1476
The extraordinary ligand binding properties of human serum albumin.
@en
P2093
Gabriella Fanali
Monica Galliano
Paolo Ascenzi
Pasquale Narciso
Stefania Notari
P304
P356
10.1080/15216540500404093
P577
2005-12-01T00:00:00Z